SCHEMBL26435148

SCHEMBL26435148

c1ccc2c(c1)ccc1cc(-c3ccc(-c4nc(-c5cccc6c5oc5ccccc56)nc(-c5cccc6ccc7ccccc7c56)n4)cc3)ccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.43
TDP1 Q9NUW8 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
PRKDC P78527 3/20 0.35
ERBB2 P04626 1/20 0.34
CYP1A2 P05177 1/20 0.34
FYN P06241 1/20 0.34
MAOA P21397 1/20 0.34
ACHE P22303 1/20 0.34
AHR P35869 1/20 0.34
PIK3CD O00329 1/20 0.34
PIK3CB P42338 1/20 0.34
GGPS1 O95749 1/20 0.33
MAPT P10636 5/20 0.33
KDM4E B2RXH2 4/20 0.33
ALDH1A1 P00352 4/20 0.33
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33
GAA P10253 1/20 0.33
POLB P06746 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26435149 0.96 ALOX5 (0.41) ALOX5TDP1L3MBTL1PRKDCCYP1A2
SCHEMBL26435109 0.95 ALOX5 (0.44) ALOX5TDP1L3MBTL1PRKDCERBB2
SCHEMBL26434996 0.94 ALOX5 (0.43) ALOX5TDP1L3MBTL1PRKDCCYP1A2
SCHEMBL26435654 0.94 ALOX5 (0.42) ALOX5TDP1L3MBTL1PRKDCPIK3CD
SCHEMBL26435020 0.93 ALOX5 (0.43) ALOX5TDP1L3MBTL1PRKDCAHR
SCHEMBL26435066 0.92 ALOX5 (0.43) ALOX5TDP1L3MBTL1PRKDCAHR
SCHEMBL26435708 0.92 ALOX5 (0.43) ALOX5TDP1L3MBTL1PRKDCCYP1A2
SCHEMBL26435011 0.92 ALOX5 (0.43) ALOX5TDP1L3MBTL1PRKDCCYP1A2
SCHEMBL26435661 0.92 ALOX5 (0.42) ALOX5TDP1L3MBTL1PRKDCCYP1A2
SCHEMBL26435010 0.91 ALOX5 (0.43) ALOX5TDP1L3MBTL1PRKDCCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 ALOX5 1266/4885TDP1 1017/4885L3MBTL1 1536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.